Connect Biopharma Holdings Ltd (CNTB) stock
CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.58−0.06 (-9.98%)
Close on Nov 17, 2026Market cap $36.45MP/E –Yield –
Connect Biopharma cash
Cash and short-term investments held at the end of each period.
Connect Biopharma's cash was $31.50M at Jun 30, 2026. For fiscal 2025 it was $44.30M, down 52.7% from the year before. The highest annual figure on record is $267.72M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.30M | -52.7% |
| FY2024 | Dec 31, 2024 | $93.70M | -20.8% |
| FY2023 | Dec 31, 2023 | $118.30M | +49.9% |
| FY2022 | Dec 31, 2022 | $78.95M | -70.5% |
| FY2021 | Dec 31, 2021 | $267.72M | +72.9% |
| FY2020 | Dec 31, 2020 | $154.80M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $31.50M | -56.1% |
| Q1 FY2026 | Mar 31, 2026 | $46.03M | -45.2% |
| Q4 FY2025 | Dec 31, 2025 | $44.30M | -52.7% |
| Q3 FY2025 | Sep 30, 2025 | $54.80M | -43.6% |
| Q2 FY2025 | Jun 30, 2025 | $71.80M | -34.6% |
| Q1 FY2025 | Mar 31, 2025 | $84.00M | -26.4% |
| Q4 FY2024 | Dec 31, 2024 | $93.70M | -20.8% |
| Q3 FY2024 | Sep 30, 2024 | $97.19M | +19.1% |
| Q2 FY2024 | Jun 30, 2024 | $109.84M | +39.1% |
| Q1 FY2024 | Mar 31, 2024 | $114.10M | -19.3% |
| Q4 FY2023 | Dec 31, 2023 | $118.30M | -55.8% |
| Q2 FY2023 | Jun 30, 2023 | $81.61M | -47.3% |
| Q4 FY2022 | Dec 31, 2022 | $78.95M | – |
| Q2 FY2022 | Jun 30, 2022 | $141.37M | – |
| Q4 FY2021 | Dec 31, 2021 | $267.72M | – |
| Q4 FY2020 | Dec 31, 2020 | $154.80M | – |
See a number that looks wrong?